 | • レポートコード：QYR9ST03709 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、前立腺癌検査の世界市場について調査・分析し、前立腺癌検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（PSAテスト、CTCテスト、免疫組織化学、PCA3テスト、その他）、用途別（病院関連研究所、独立診断研究所、癌研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の前立腺癌検査市場動向 ・主要企業別マーケットシェア ・前立腺癌検査の種類別市場規模2014-2019 （PSAテスト、CTCテスト、免疫組織化学、PCA3テスト、その他） ・前立腺癌検査の用途別市場規模2014-2019 （病院関連研究所、独立診断研究所、癌研究所、その他） ・前立腺癌検査の北米市場：主要企業・種類別/用途別市場規模 ・前立腺癌検査のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・前立腺癌検査の中国市場：主要企業・種類別/用途別市場規模 ・前立腺癌検査の日本国内市場：主要企業・種類別/用途別市場規模 ・前立腺癌検査の東南アジア市場：主要企業・種類別/用途別市場規模 ・前立腺癌検査のインド市場：主要企業・種類別/用途別市場規模 ・前立腺癌検査の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Genomic Health、OPKO、Siemens Healthcare、DiaSorin、bioMeriux、Roche、MDx Health、Beckman Coulter、Myriad Genetics、Ambry Genetics） ・前立腺癌検査の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
There are many new drugs that have increased the life expectancy of prostate cancer patients and have been approved by the Food & Drug Administration. But these drugs are having a high cost, which is a threat for the patients and the insurers, both. These expensive drugs are not being paid by the insurance companies and the reimbursement level for them is very low. Hence, only few people are capable of affording these drugs. Therefore, because of this high cost, the use of generic drugs is more, and hence, it is hindering the growth of the prostate cancer drugs market.
North America is the leading global market with the largest revenue share in 2017. Due to the rising prevalence of the diseases and high mortality rate of the prostate cancer in the United States, North America is dominating the market. Asia-Pacific is also projected to be the fastest growing region due to the improving healthcare infrastructure and the growing investments by the key market players.
In 2018, the global Prostate Cancer Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Prostate Cancer Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Testing development in United States, Europe and China.
The key players covered in this study
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Market segment by Type, the product can be split into
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Market segment by Application, split into
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Prostate Cancer Testing status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Prostate Cancer Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 PSA Tests
1.4.3 CTC Tests
1.4.4 Immunohistochemistry
1.4.5 PCA3 Tests
1.4.6 Others
1.5 Market by Application
1.5.1 Global Prostate Cancer Testing Market Share by Application (2014-2025)
1.5.2 Hospital Associated Labs
1.5.3 Independent Diagnostic Laboratories
1.5.4 Cancer Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Prostate Cancer Testing Market Size
2.2 Prostate Cancer Testing Growth Trends by Regions
2.2.1 Prostate Cancer Testing Market Size by Regions (2014-2025)
2.2.2 Prostate Cancer Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Prostate Cancer Testing Market Size by Manufacturers
3.1.1 Global Prostate Cancer Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Prostate Cancer Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Testing Key Players Head office and Area Served
3.3 Key Players Prostate Cancer Testing Product/Solution/Service
3.4 Date of Enter into Prostate Cancer Testing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Prostate Cancer Testing Market Size by Type (2014-2019)
4.2 Global Prostate Cancer Testing Market Size by Application (2014-2019)
5 United States
5.1 United States Prostate Cancer Testing Market Size (2014-2019)
5.2 Prostate Cancer Testing Key Players in United States
5.3 United States Prostate Cancer Testing Market Size by Type
5.4 United States Prostate Cancer Testing Market Size by Application
6 Europe
6.1 Europe Prostate Cancer Testing Market Size (2014-2019)
6.2 Prostate Cancer Testing Key Players in Europe
6.3 Europe Prostate Cancer Testing Market Size by Type
6.4 Europe Prostate Cancer Testing Market Size by Application
7 China
7.1 China Prostate Cancer Testing Market Size (2014-2019)
7.2 Prostate Cancer Testing Key Players in China
7.3 China Prostate Cancer Testing Market Size by Type
7.4 China Prostate Cancer Testing Market Size by Application
8 Japan
8.1 Japan Prostate Cancer Testing Market Size (2014-2019)
8.2 Prostate Cancer Testing Key Players in Japan
8.3 Japan Prostate Cancer Testing Market Size by Type
8.4 Japan Prostate Cancer Testing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Prostate Cancer Testing Market Size (2014-2019)
9.2 Prostate Cancer Testing Key Players in Southeast Asia
9.3 Southeast Asia Prostate Cancer Testing Market Size by Type
9.4 Southeast Asia Prostate Cancer Testing Market Size by Application
10 India
10.1 India Prostate Cancer Testing Market Size (2014-2019)
10.2 Prostate Cancer Testing Key Players in India
10.3 India Prostate Cancer Testing Market Size by Type
10.4 India Prostate Cancer Testing Market Size by Application
11 Central & South America
11.1 Central & South America Prostate Cancer Testing Market Size (2014-2019)
11.2 Prostate Cancer Testing Key Players in Central & South America
11.3 Central & South America Prostate Cancer Testing Market Size by Type
11.4 Central & South America Prostate Cancer Testing Market Size by Application
12 International Players Profiles
12.1 Genomic Health
12.1.1 Genomic Health Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate Cancer Testing Introduction
12.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2014-2019)
12.1.5 Genomic Health Recent Development
12.2 OPKO
12.2.1 OPKO Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate Cancer Testing Introduction
12.2.4 OPKO Revenue in Prostate Cancer Testing Business (2014-2019)
12.2.5 OPKO Recent Development
12.3 Siemens Healthcare
12.3.1 Siemens Healthcare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate Cancer Testing Introduction
12.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2014-2019)
12.3.5 Siemens Healthcare Recent Development
12.4 DiaSorin
12.4.1 DiaSorin Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate Cancer Testing Introduction
12.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2014-2019)
12.4.5 DiaSorin Recent Development
12.5 bioMeriux
12.5.1 bioMeriux Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate Cancer Testing Introduction
12.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2014-2019)
12.5.5 bioMeriux Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate Cancer Testing Introduction
12.6.4 Roche Revenue in Prostate Cancer Testing Business (2014-2019)
12.6.5 Roche Recent Development
12.7 MDx Health
12.7.1 MDx Health Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate Cancer Testing Introduction
12.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2014-2019)
12.7.5 MDx Health Recent Development
12.8 Beckman Coulter
12.8.1 Beckman Coulter Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate Cancer Testing Introduction
12.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2014-2019)
12.8.5 Beckman Coulter Recent Development
12.9 Myriad Genetics
12.9.1 Myriad Genetics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prostate Cancer Testing Introduction
12.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2014-2019)
12.9.5 Myriad Genetics Recent Development
12.10 Ambry Genetics
12.10.1 Ambry Genetics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prostate Cancer Testing Introduction
12.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2014-2019)
12.10.5 Ambry Genetics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Prostate Cancer Testing Key Market Segments
Table Key Players Prostate Cancer Testing Covered
Table Global Prostate Cancer Testing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Prostate Cancer Testing Market Size Market Share by Type 2014-2025
Figure PSA Tests Figures
Table Key Players of PSA Tests
Figure CTC Tests Figures
Table Key Players of CTC Tests
Figure Immunohistochemistry Figures
Table Key Players of Immunohistochemistry
Figure PCA3 Tests Figures
Table Key Players of PCA3 Tests
Figure Others Figures
Table Key Players of Others
Table Global Prostate Cancer Testing Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Associated Labs Case Studies
Figure Independent Diagnostic Laboratories Case Studies
Figure Cancer Research Institutes Case Studies
Figure Others Case Studies
Figure Prostate Cancer Testing Report Years Considered
Table Global Prostate Cancer Testing Market Size 2014-2025 (Million US$)
Figure Global Prostate Cancer Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Prostate Cancer Testing Market Size by Regions 2014-2025 (Million US$)
Table Global Prostate Cancer Testing Market Size by Regions 2014-2019 (Million US$)
Table Global Prostate Cancer Testing Market Share by Regions 2014-2019
Figure Global Prostate Cancer Testing Market Share by Regions 2014-2019
Figure Global Prostate Cancer Testing Market Share by Regions 2019
Table Market Top Trends
Table Global Prostate Cancer Testing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Prostate Cancer Testing Market Share by Manufacturers (2014-2019)
Figure Global Prostate Cancer Testing Market Share by Manufacturers in 2018
Table Global Prostate Cancer Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prostate Cancer Testing Product/Solution/Service
Table Date of Enter into Prostate Cancer Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table Global Prostate Cancer Testing Market Size Share by Type (2014-2019)
Figure Global Prostate Cancer Testing Market Size Market Share by Type (2014-2019)
Table Global Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table Global Prostate Cancer Testing Market Size Share by Application (2014-2019)
Figure Global Prostate Cancer Testing Market Size Market Share by Application (2014-2019)
Figure Global Prostate Cancer Testing Revenue Market Share by Application in 2018
Figure United States Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table United States Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table United States Key Players Prostate Cancer Testing Market Share (2018-2019)
Table United States Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table United States Prostate Cancer Testing Market Share by Type (2014-2019)
Table United States Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table United States Prostate Cancer Testing Market Share by Application (2014-2019)
Figure Europe Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Prostate Cancer Testing Market Share (2018-2019)
Table Europe Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table Europe Prostate Cancer Testing Market Share by Type (2014-2019)
Table Europe Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table Europe Prostate Cancer Testing Market Share by Application (2014-2019)
Figure China Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table China Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table China Key Players Prostate Cancer Testing Market Share (2018-2019)
Table China Prostate Cancer Testing Market Size by Type (2014-20189) (Million US$)
Table China Prostate Cancer Testing Market Share by Type (2014-2019)
Table China Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table China Prostate Cancer Testing Market Share by Application (2014-2019)
Figure Japan Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Prostate Cancer Testing Market Share (2018-2019)
Table Japan Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table Japan Prostate Cancer Testing Market Share by Type (2014-2019)
Table Japan Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table Japan Prostate Cancer Testing Market Share by Application (2014-2019)
Figure Southeast Asia Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Prostate Cancer Testing Market Share (2018-2019)
Table Southeast Asia Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Prostate Cancer Testing Market Share by Type (2014-2019)
Table Southeast Asia Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Prostate Cancer Testing Market Share by Application (2014-2019)
Figure India Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table India Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table India Key Players Prostate Cancer Testing Market Share (2018-2019)
Table India Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table India Prostate Cancer Testing Market Share by Type (2014-2019)
Table India Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table India Prostate Cancer Testing Market Share by Application (2014-2019)
Figure Central & South America Prostate Cancer Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Prostate Cancer Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Prostate Cancer Testing Market Share (2018-2019)
Table Central & South America Prostate Cancer Testing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Prostate Cancer Testing Market Share by Type (2014-2019)
Table Central & South America Prostate Cancer Testing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Prostate Cancer Testing Market Share by Application (2014-2019)
Table Genomic Health Company Details
Table Genomic Health Revenue in Prostate Cancer Testing Business (2014-2019) (Million US$)
Figure Genomic Health Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table Genomic Health Recent Development
Table OPKO Company Details
Table OPKO Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure OPKO Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table OPKO Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table Siemens Healthcare Recent Development
Table DiaSorin Company Details
Table DiaSorin Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure DiaSorin Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table DiaSorin Recent Development
Table bioMeriux Company Details
Table bioMeriux Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure bioMeriux Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table bioMeriux Recent Development
Table Roche Company Details
Table Roche Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table Roche Recent Development
Table MDx Health Company Details
Table MDx Health Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure MDx Health Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table MDx Health Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table Beckman Coulter Recent Development
Table Myriad Genetics Company Details
Table Myriad Genetics Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure Myriad Genetics Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table Myriad Genetics Recent Development
Table Ambry Genetics Company Details
Table Ambry Genetics Revenue in Prostate Cancer Testing Business (2014-2019)(Million US$)
Figure Ambry Genetics Revenue Growth Rate in Prostate Cancer Testing Business (2014-2019)
Table Ambry Genetics Recent Development
Table Global Prostate Cancer Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Prostate Cancer Testing Market Size Share by Regions (2019-2025)
Figure Global Prostate Cancer Testing Market Size Share by Regions in 2025
Figure United States Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Prostate Cancer Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Prostate Cancer Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Prostate Cancer Testing Market Size by Product (2019-2025)
Figure Global Prostate Cancer Testing Market Size by Product in 2025
Table Global Prostate Cancer Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Prostate Cancer Testing Market Size by Application (2019-2025)
Figure Global Prostate Cancer Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
子宮頸が診断検査の世界市場：市場規模・現状・予測 Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body.In 2018, the global Cervical Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the en…- 乳がんスクリーニング検査の世界市場：市場規模・現状・予測 Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- 体外大腸癌スクリーニング検査の世界市場：市場規模・現状・予測 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal can…
- 前立腺癌の世界市場：市場規模・現状・予測 Prostate cancer is cancer that occurs in the prostate.In 2018, the global Prostate Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Prostate Cancer status, future forecast, grow…
- 前立腺癌治療の世界市場：市場規模・現状・予測 Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.In 2018, the global Prostate Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAG…